~~<i id='2058282B57'><strike id='2058282B57'><tt id='2058282B57'><pre id='2058282B57'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：knowledge 2025-10-01 02:19:55 Page View：18

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire
Next article： At least 13 dead in Texas as scorching temps continue

leisure time

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Racing yachts have close encounter with pod of orcas near Strait of Gibraltar

1:30Twosixty-five-footraceyachtshadacloseencounterwithorcawhalesastheyapproachedtheStraitofGibraltar

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Hospitals need to get ahead of regulations on climate change

St.ClaireRegionalMedicalCenterinMorehead,Ky.TheU.S.healthcaredeliverysystemaccountsforabout8.5%ofall